Management of Herpes Zoster in a Productive Age Female Patient: A Case Report

Authors

  • Arfa Salma Firnandya Universitas Lampung
  • Reni Zuraida Bagian Ilmu Kedokteran Komunitas, Fakultas Kedokteran Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v17i1.1973

Keywords:

Herpes zoster, treatment, young adult

Abstract

Herpes zoster is caused by the reactivation of latent Varicella-zoster virus (VZV) following primary varicella infection. Although it is more common among older adults, it may also occur in productive-age individuals with risk factors such as psychological stress, sleep deprivation, and unhealthy lifestyles. This case report describes the comprehensive management of herpes zoster in a productive-age woman. A 19-year-old woman presented with painful, pruritic, and burning vesicular eruptions on the right posterior lumbar region for four days. Dermatological examination revealed multiple erythematous vesiculobullous lesions with a unilateral dermatomal distribution. The patient had a history of childhood varicella, high academic stress, inadequate sleep, low physical activity, and poor dietary habits. A clinical diagnosis of herpes zoster of the right posterior lumbar region was established. The patient received oral acyclovir 800 mg five times daily, topical acyclovir 5%, paracetamol, cetirizine, and vitamin C for seven days. Non-pharmacological interventions included education regarding the disease, stress management, sleep improvement, physical activity, balanced nutrition, and family support. Follow-up evaluation demonstrated reduced pain, pruritus, and burning sensation, drying of lesions without new eruptions, and improved knowledge and health-related behaviors. A comprehensive approach integrating antiviral therapy, patient education, lifestyle modification, and family support resulted in favorable clinical outcomes and may help prevent complications and recurrence in productive-age patients with herpes zoster.

References

World Health Organization. (2025). Shingles (herpes zoster). WHO. Diambil dari https://www.who.int/news-room/fact-sheets/detail/herpes-zoster-(shingles).

Harvey, M., Prosser, L. A., Rose, A. M., et al. (2020). Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition. Pain, 161, 361–368.

Wu, Z., Wei, J., Xu, W., Wu, J., & Jiang, M. (2025). Global burden of varicella and herpes zoster across 204 countries, 1990–2021: a temporal trend analysis in the era of the COVID-19 pandemic and projections to 2036. Frontiers in Public Health, 13.

Chen, J., Abrahamson, P. E., Ke, Y., Chin Rong Ong, Parikh, R., & Sumitra Shantakumar. (2024). A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific. Human Vaccines & Immunotherapeutics, 20(1).

Han, R., San, M.P., Ahmed, N., Guzman-Holst, A., Mohy, A., Pinto, T., et al. (2024). Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious Diseases and Therapy.

Sari, D., & None Wizar Putri Mellaratna. (2023). Herpes Zoster. Jurnal Riset Rumpun Ilmu Kedokteran, 2(2), 41–49.

Thabrany, H. (2025). White Paper: Kajian Herpes Zoster berdasarkan data klaim JKN 2015–2022. Jakarta : Kalta Bina Insani Consulting & Training.

Nair, P. A., & Patel, B. C. (2021). Herpes zoster. In StatPearls. StatPearls Publishing.

Barakat, S., Dankar, R., Aldalahmeh, M., Barakat, M., & Mobarakai, N. (2024). Atypical Presentation of Painless Herpes Zoster in an Elderly Male: A Case Report. Cureus.

van Oorschot, D., Vroling, H., Bunge, E., Diaz-Decaro, J., Curran, D., & Yawn, B. (2021). A systematic literature review of herpes zoster incidence worldwide. Human Vaccines & Immunotherapeutics, 17(6), 1714–1732.

Patil, A., Goldust, M., & Wollina, U. (2022). Herpes zoster: A Review of Clinical Manifestations and Management. Viruses, 14(2), 192.

Zhi, D., Hong Liang Tey, Mae, B., Ee, J., Ee-Jin Darren Seah, Nisha Suyien Chandran and Jiun Yit Pan (2024). Herpes Zoster and Post-Herpetic Neuralgia: Diagnosis, Treatment, and Vaccination Strategies. Pathogens, 13(7), pp.596–596.

Oleszko, M., Zapolnik, P., Kmiecik, W. and Czajka, H. (2025). Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients. Diseases, 13(3), p.71.

Kim, Y. and Lee, W. (2025). Increased risk of herpes zoster associated with stress and sleep deprivation: Evidence from korea health panel survey. Journal of Psychiatric Research, 184, pp.333–339.

Centers for Disease Control and Prevention. (2024). Clinical Features of Shingles (Herpes Zoster). CDC. Diambil dari https://www.cdc.gov/shingles/hcp/clinical-signs/index.html

Published

2026-07-09

How to Cite

Firnandya, A. S., & Zuraida, R. (2026). Management of Herpes Zoster in a Productive Age Female Patient: A Case Report. Medical Profession Journal of Lampung, 17(1), 192-198. https://doi.org/10.53089/medula.v17i1.1973

Issue

Section

Artikel

Most read articles by the same author(s)

1 2 3 > >>